GoldenGolden
Advanced Search
HIV

HIV

Human immunodeficiency virus (HIV) is a type of retrovirus, that if left untreated can lead to AIDs (Acquired ImmunoDeficiency Syndrome.

Human immunodeficiency virus (HIV) is a type of retrovirus, that if left untreated can lead to AIDs (acquired immunodeficiency syndrome).

Timeline

September 11, 2019
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

Researchers based in China used CRISPR to edit hematopoietic stem and progenitor cells (HSPCs) to make the gene CCR5 non-functional, which makes cells resistant to HIV-1. The CRISPR-edited CCR5-ablated HSPCs were transplanted into a patient with HIV-1 infection and acute lymphoblastic leukemia, which was in remission. Although there was long-term engraftment of the edited HSPCs, only about 5% of lymphocytes contained the CCR5 disruption.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
December 3, 2021
AP NEWS
Here's a look at what The Conversation, a non-profit source of explanatory journalism from experts in academia, is offering today.AP members may find The Conversation content on AP Newsroom or through AP webfeeds.
By EDITH M. LEDERER
December 1, 2021
AP NEWS
UNITED NATIONS (AP) -- Dr. Anthony Fauci, the top U.S. infectious disease expert, said Tuesday the COVID-19 pandemic has diverted scientific and financial resources from the fight against AIDS, seriously impeding global efforts to achieve the U.N.
Paige Minemyer
September 27, 2021
FierceHealthcare
CVS Caremark is expanding its health equity efforts, setting goals that specifically target diseases that disproportionately impact patients of color, such as HIV and sickle cell disease.
Arlene Weintraub
September 27, 2021
FierceBiotech
Researchers led by the City of Hope have developed a novel drug-delivery system that can carry an anti-HIV drug cargo into the brain and other remote tissues in mice, locking the virus into a dormant state. They believe the advance could ultimately be applied to a range of diseases.
Annalee Armstrong
September 17, 2021
FierceBiotech
A CRISPR-Cas9 gene editing technology that has shown promise in clearing HIV from mice is headed into human testing. Excision BioTherapeutics will usher the CRISPR-based therapy EBT-101 into clinical trials after the FDA cleared an investigational new drug application.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.